Purpose: To compare IMRT planning strategies for prostate cancer patients with metal hip prostheses.
Methods: All plans were generated fully automatically (i.e., no human trial-and-error interactions) using iCycle, the authors' in-house developed algorithm for multicriterial selection of beam angles and optimization of fluence profiles, allowing objective comparison of planning strategies. For 18 prostate cancer patients (eight with bilateral hip prostheses, ten with a right-sided unilateral prosthesis), two planning strategies were evaluated: (i) full exclusion of beams containing beamlets that would deliver dose to the target after passing a prosthesis (IMRTremove) and (ii) exclusion of those beamlets only (IMRTcut). Plans with optimized coplanar and noncoplanar beam arrangements were generated. Differences in PTV coverage and sparing of organs at risk (OARs) were quantified. The impact of beam number on plan quality was evaluated.
Results: Especially for patients with bilateral hip prostheses, IMRTcut significantly improved rectum and bladder sparing compared to IMRTremove. For 9-beam coplanar plans, rectum V60Gy reduced by 17.5% ± 15.0% (maximum 37.4%, p = 0.036) and rectum Dmean by 9.4% ± 7.8% (maximum 19.8%, p = 0.036). Further improvements in OAR sparing were achievable by using noncoplanar beam setups, reducing rectum V60Gy by another 4.6% ± 4.9% (p = 0.012) for noncoplanar 9-beam IMRTcut plans. Large reductions in rectum dose delivery were also observed when increasing the number of beam directions in the plans. For bilateral implants, the rectum V60Gy was 37.3% ± 12.1% for coplanar 7-beam plans and reduced on average by 13.5% (maximum 30.1%, p = 0.012) for 15 directions.
Conclusions: iCycle was able to automatically generate high quality plans for prostate cancer patients with prostheses. Excluding only beamlets that passed through the prostheses (IMRTcut strategy) significantly improved OAR sparing. Noncoplanar beam arrangements and, to a larger extent, increasing the number of treatment beams further improved plan quality.
Written by:
Voet PW, Dirkx ML, Breedveld S, Heijmen BJ. Are you the author?
Erasmus MC - Daniel den Hoed Cancer Center, Department of Radiation Oncology, Groene Hilledijk 301, 3075EA Rotterdam, The Netherlands.
Reference: Med Phys. 2013 Jul;40(7):071704.
doi: 10.1118/1.4808117
PubMed Abstract
PMID: 23822408
UroToday.com Prostate Cancer Section
